Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Finance Watch: PTC Raises $1bn In Evrysdi Royalty Deal Weeks After Latest Layoffs

Abivax Launches 19th US Biopharma IPO Of 2023

Oct 20 2023

• By Mandy Jackson

Finance Watch Public Company — • Source: Alamy

Related Content

Takeda Takes Back Dravet, Lennox-Gastaut Candidate From Ovid

Mar 03 2021

Finance Watch: Ten IPOs In One Week Bring 2021 Total To 80

Aug 02 2021

Finance Watch: With Four More IPOs, July May Match Or Exceed June’s 14

Jul 24 2020

Evelo Forges Ahead In Psoriasis As Atopic Dermatitis Pathway Narrows

Feb 01 2023

Egetis Ends Takeover Talks To Focus On Emcitate

May 26 2023

PTC Misses Phase III In Friedrich Ataxia, But Isn’t Giving Up

May 24 2023

Scholar Rock Looks To Augment Existing Therapies In Spinal Muscular Atrophy

Jul 03 2023

Can Beam Keep Up With Sickle Cell Gene Therapy Frontrunners? Investors Are Unconvinced

Oct 20 2023

Sanofi Matches, But Does Not Better, Amgen In OX40 Contest

Oct 17 2023

Finance Watch: Lucky Few Raise Cash While Many Public Biotechs Cut Costs

Apr 12 2023

Finance Watch: FibroGen, Amarin And Others Downsize To Survive

Jul 19 2023

Deal Watch: Tourmaline Will Pursue Its Thyroid Eye Disease Ambitions Following Merger With Talaris

Jun 23 2023

Finance Watch: PTC Secures Up To $1bn In Funding From Blackstone

Nov 04 2022

New Era For Schizophrenia Therapy Beckons As Karuna Soars On Promising Phase III Data

Aug 09 2022

With Hopeful Interim Data, Ultragenyx Bets On GeneTx, Angelman Syndrome Candidate

Jul 20 2022

Arcutis’s Zoryve Succeeds In Second Phase III In Atopic Dermatitis

Dec 12 2022

Related Companies

PTC Therapeutics, Inc.

Royalty Pharma plc

Roche Holding AG

Cerevel Therapeutics Holdings, Inc.

Karuna Therapeutics, Inc.

Ultragenyx Pharmaceutical Inc.

Nuvalent, Inc.

Arcutis Biotherapeutics, Inc.

Scholar Rock, LLC

Talaris Therapeutics, Inc.

Astria Therapeutics, Inc.

Ichnos Glenmark Innovation

Sanofi

Amgen, Inc.

Ardelyx Inc.

Egetis Therapeutics AB

Ovid Therapeutics, Inc.

Ligand Pharmaceuticals, Inc.

Takeda Pharmaceutical Co. Ltd.

Nkarta, Inc.

Beam Therapeutics Inc.

Spur Therapeutics Limited

Evelo Biosciences, Inc.

Bellerophon Therapeutics Inc.

Additional Topics

Financing Restructuring Strategy Commercial Finance Watch BioPharmaceutical

More from Financing

More from Business

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window